News About: Pharm. Industry
Hanmi received KT mark on Amodipin.Hanmi recently received the domestic technology award of "Excellent Korean Technology" for Amodipin, an anti-hypertension drug during the Q3 2005 Technology Recognition occasion...
|
Hanyak Maul to construct GMP plant for hyaluronic acid production.Hanyak Maul Inc. is a venture company founded by the college students and professors of Kyunghee Univ. College of Herbal Pharmacy at 200 million won of the capital supported by ...
|
KPTA wanted companies to participate in 54th PharmChina exhibition.
The Korea Pharmaceutical Trade Association (KPTA) invited the candidates until Sept. 20 who wish to participate in the 54th PharmChina exhibition at Chongqing International Convention & Exhibition Center from Dec. 1 t...
Il Yang licensing out Ilaprazole to Tap Co.
Il yang announced on Sept. 7 that a technical transfer of Ilaprazole, an anti-peptic ulcer drug, was agreed with Tap Pharmaceutical Products Inc. in the United States (a joint venture company between Abbott of the Uni...
Daewoong to propose exclusive distributorship on specific products.
Daewoong proposed to its associated wholesalers for an exclusive distribution of specific products so that the company boosts sales increases of the unpopular products while the associated wholesalers get more sales m...
AZ Korea to celebrate Arimidex NHI coverage.
AstraZeneca Korea celebrated an event called "Love Confession of Arimidex" at the head office on Sept. 5 for the occasion of the NHI reimbursement approval on Arimidex.
The ceremony also purported for the staffs an...
Hurim BioCell to operate a stem cell bank business.
Hurim BioCell announced a stem cell bank business comprising of a stem cell extraction from the hips or abdomens of adults and a freezing storage.
Unlike an umbilical code blood business of new baby birth, the com...
Chongkundang to launch Clobone for growing adolescents.Chongkundang has launched a functional supplement food product for the physical and skeletal development of the growing adolescents with nutritional components in consideration ...
|
Kuhnil to sign an exclusive distribution of anticancer drug with Regulon Inc.
Kuhnil announced on Sept. 6 that an agreement was signed with Regulon Inc. for the exclusive distribution of an anti-cancer drug, Lipoplatin, in Korea, which is a lipsome preparation of Cisplastin, showing better prof...
Deputy KFDA commissioner and high MOHW officer nominated.
The government appointed Mr. Kim Myeong-hyeon, ex-director of the Health Policy Bureau, MOHW, as the deputy chief commissioner of KFDA (1st grade equivalent officer) as of Sept. 7, and Mr. Moon Chang-jin, the former M...